Daiwa Securities Group
SMMT icon

Daiwa Securities Group’s Summit Therapeutics SMMT Stock Holding History

Daiwa Securities Group’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,157
Closed -$38K – 1406
2025
Q4 		$38K Sell
2,157
-10,507
-83% -$198K ﹤0.01% 1134
2025
Q3 		$262K Buy
12,664
+10,100
+394% +$245K ﹤0.01% 960
2025
Q2 		$55K Sell
2,564
-11,695
-82% -$267K ﹤0.01% 1058
2025
Q1 		$275K Buy
14,259
+11,825
+486% +$237K ﹤0.01% 900
2024
Q4 		$43K Sell
2,434
-225
-8% -$4.36K ﹤0.01% 1068
2024
Q3 		$58K Hold
2,659
– – ﹤0.01% 1055
2024
Q2 		$21K Sell
2,659
-69
-3% -$373 ﹤0.01% 1133
2024
Q1 		$11K Hold
2,728
– – ﹤0.01% 1163
2023
Q4 		$7K Hold
2,728
– – ﹤0.01% 1188
2023
Q3 		$5K Hold
2,728
– – ﹤0.01% 1164
2023
Q2 		$7K Hold
2,728
– – ﹤0.01% 1157
2023
Q1 		$5K Buy
2,728
+1,918
+237% +$5.23K ﹤0.01% 1158
2022
Q4 		$3K Buy
810
+476
+143% +$866 ﹤0.01% 1206
2022
Q3 		$0 Hold
334
– – ﹤0.01% 1389
2022
Q2 		$0 Hold
334
– – ﹤0.01% 1419
2022
Q1 		$1K Hold
334
– – ﹤0.01% 1338
2021
Q4 		$1K Hold
334
– – ﹤0.01% 1361
2021
Q3 		$2K Buy
334
+179
+115% +$1.28K ﹤0.01% 1248
2021
Q2 		$1K Hold
155
– – ﹤0.01% 1211
2021
Q1 		$1K Hold
155
– – ﹤0.01% 1222
2020
Q4 		$1K Buy
+155
New +$656 ﹤0.01% 1202

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Daiwa Securities Group's SMMT Position: Q1 2026 in Review

Daiwa Securities Group sold out of Summit Therapeutics (SMMT) in Q1 2026, closing a stake of 2,157 shares — an estimated $38K sold.

Daiwa Securities Group first reported a position in SMMT in Q4 2020 and held it in 21 quarters. The position peaked at $275K in Q1 2025. 222 funds tracked by Wall St. Rank hold SMMT as of Q1 2026.

  • Daiwa Securities Group reported no remaining Summit Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 2,157 Summit Therapeutics shares in Q1 2026, an estimated $38K.
  • Daiwa Securities Group first reported a position in Summit Therapeutics in Q4 2020 and held it in 21 quarters.
  • Daiwa Securities Group's Summit Therapeutics position peaked at $275K in Q1 2025.
  • 222 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.